LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NYSE: PBYI), a development stage
biopharmaceutical company, announced financial results for the fourth
quarter and year ended December 31, 2014.
Unless otherwise stated, all comparisons are for the fourth quarter and
full year 2014 compared to the fourth quarter and full year 2013,
Based on accounting principles generally accepted in the United States
(GAAP), Puma reported a netmore...